VYNE THERAPEUTICS INC
(NASDAQ: VYNE)
VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercialize solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company was founded on October 21, and is headquartered in Bridgewater, NJ.
2.760
-
(-%)
Range
- - -
(-%)
Open
-
Previous Close
2.760
Bid Price
6.900
Bid Volume
9
Ask Price
7.080
Ask Volume
11
Volume
2,534
Value
-
Remark
Delayed prices. Updated at 15 May 2024 12:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
